Penumbra, Inc Operating Lease Cost
Penumbra, Inc (PEN) reported Operating Lease Cost of $24.09 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-25
- Penumbra, Inc operating lease, cost for the quarter ending 2022-12-31 was $5.26M, a 25.74% increase year-over-year.
- Penumbra, Inc operating lease, cost for the quarter ending 2022-09-30 was $5.13M, a 43.11% increase year-over-year.
- Penumbra, Inc operating lease, cost for the quarter ending 2022-06-30 was $5.03M, a 156.97% increase year-over-year.
- Penumbra, Inc operating lease, cost for the quarter ending 2022-03-31 was $4.88M, a 154.40% increase year-over-year.
- Penumbra, Inc operating lease, cost for fiscal 2025 was $24.09M, a 2.32% increase from fiscal 2024.
- Penumbra, Inc operating lease, cost for fiscal 2024 was $23.54M, a 2.55% increase from fiscal 2023.
- Penumbra, Inc operating lease, cost for fiscal 2023 was $22.95M, a 13.05% increase from fiscal 2022.
- Penumbra, Inc operating lease, cost for fiscal 2022 was $20.30M, a 74.35% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $24.09M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $23.54M 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $22.95M 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $5.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $10.39M derived: sum of 2 quarters · filed 2025-02-18 | $15.42M derived: sum of 3 quarters · filed 2025-02-18 | $20.30M 10-K · filed 2025-02-18 |
| 2022-09-30 | $5.13M 10-Q · filed 2022-11-03 | $10.17M derived: sum of 2 quarters · filed 2022-11-03 | $15.05M 10-Q · filed 2022-11-03 | $19.23M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $5.03M 10-Q · filed 2022-08-05 | $9.92M 10-Q · filed 2022-08-05 | $14.10M derived: sum of 3 quarters · filed 2024-02-22 | $17.68M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $4.88M 10-Q · filed 2022-05-03 | $9.06M derived: sum of 2 quarters · filed 2024-02-22 | $12.65M derived: sum of 3 quarters · filed 2024-02-22 | $14.61M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $7.77M derived: sum of 2 quarters · filed 2024-02-22 | $9.73M derived: sum of 3 quarters · filed 2024-02-22 | $11.65M 10-K · filed 2024-02-22 |
| 2021-09-30 | $3.59M 10-Q · filed 2022-11-03 | $5.54M derived: sum of 2 quarters · filed 2022-11-03 | $7.46M 10-Q · filed 2022-11-03 | $9.35M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.96M 10-Q · filed 2022-08-05 | $3.88M 10-Q · filed 2022-08-05 | $5.76M derived: sum of 3 quarters · filed 2023-02-23 | $7.68M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.92M 10-Q · filed 2022-05-03 | $3.81M derived: sum of 2 quarters · filed 2023-02-23 | $5.72M derived: sum of 3 quarters · filed 2023-02-23 | $7.63M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $3.80M derived: sum of 2 quarters · filed 2023-02-23 | $5.71M derived: sum of 3 quarters · filed 2023-02-23 | $7.60M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.92M 10-Q · filed 2021-11-03 | $3.82M derived: sum of 2 quarters · filed 2021-11-03 | $5.71M 10-Q · filed 2021-11-03 | $7.92M derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $1.91M 10-Q · filed 2020-08-03 | $3.79M 10-Q · filed 2020-08-03 | $6.00M derived: sum of 3 quarters · filed 2021-02-23 | $7.63M derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-03-31 | $1.89M 10-Q · filed 2020-05-07 | $4.09M derived: sum of 2 quarters · filed 2021-02-23 | $5.73M derived: sum of 3 quarters · filed 2021-02-23 | $7.41M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $3.84M derived: sum of 2 quarters · filed 2021-02-23 | $5.53M derived: sum of 3 quarters · filed 2021-02-23 | $7.29M 10-K · filed 2021-02-23 |
| 2019-09-30 | $1.63M 10-Q · filed 2019-11-07 | $3.32M derived: sum of 2 quarters · filed 2020-08-03 | $5.08M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.69M 10-Q · filed 2020-08-03 | $3.45M 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $1.77M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |